India to Iraq: Amikacin Export Trade Route
India has recorded 101 verified shipments of Amikacin exported to Iraq, representing a combined trade value of $4.9M USD. This corridor is served by 35 active Indian exporters, with an average shipment value of $48.5K USD. The leading Indian exporter is AJANTA PHARMA LIMITED, which accounts for 20% of total export value with 21 shipments worth $990.3K USD. On the buying side, AL NIMAA SCIENTIFIC BUREAU is the largest importer in Iraq with $890.0K USD in purchases. The top 3 suppliers — AJANTA PHARMA LIMITED, LYKA LABS LIMITED , BRAWN LABORATORIES LIMITED — together control 53% of total trade value on this route. All data sourced from Indian Customs (DGFT) shipping bill records. Values reported in FOB USD.
Route Intelligence Overview
The India to Iraq Amikacin corridor is one of India's established pharmaceutical export routes, with 101 shipments documented worth a combined $4.9M USD. The route is dominated by AJANTA PHARMA LIMITED, which alone accounts for roughly 20% of all export value, reflecting the consolidated nature of India's amikacin manufacturing sector.
Across 35 active suppliers, the average shipment value stands at $48.5K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Freight is split between sea (69%) and air (18%), suggesting a mix of scheduled bulk orders and time-sensitive consignments.
Shipment activity peaks during July–September, with an average transit time of 23 days port-to-port. The route has recorded an annual growth rate of 24.7%, placing it at rank #19 among India's top amikacin export destinations globally.
On the import side, key buyers of Indian amikacin in Iraq include AL NIMAA SCIENTIFIC BUREAU , Hawkary Pharmaceuitcal Co. , IBN SINA SCIENTIFIC BUREAU and 42 others. AL NIMAA SCIENTIFIC BUREAU is the single largest importer with 7 shipments valued at $890.0K USD.
